Bard Associates Inc. Purchases New Shares in LGL Group, Inc. (The) $LGL

Key Points

• Bard Associates acquired 488,923 LGL Group shares valued at approximately $3.38 million, giving the fund a 7.48% stake. Institutional investors collectively own 30.28% of the company.
• LGL Group reported a quarterly loss of $0.06 per share, missing the $0.01 consensus estimate, while revenue of $0.75 million fell short of expectations of $0.80 million.
• The stock opened at $7.60, near its 52-week high of $7.81. Analysts maintain a consensus “Hold” rating, with projected full-year EPS of negative $0.06.

Bard Associates Inc. acquired a new position in shares of LGL Group, Inc. (The) (NYSEAMERICAN:LGL - Free Report) during the second quarter, according to its most recent disclosure with the Securities and Exchange Commission. The fund acquired 488,923 shares of the industrial products company's stock, valued at approximately $3,378,000. Bard Associates Inc. owned about 7.48% of LGL Group at the end of the most recent reporting period.

Several other institutional investors have also recently made changes to their positions in the company. Osaic Holdings Inc. raised its holdings in shares of LGL Group by 15.5% in the second quarter. Osaic Holdings Inc. now owns 20,250 shares of the industrial products company's stock valued at $154,000 after purchasing an additional 2,710 shares during the last quarter. Citadel Advisors LLC purchased a new stake in LGL Group in the 3rd quarter valued at about $90,000. Gamco Investors INC. ET AL increased its stake in LGL Group by 2.8% in the 1st quarter. Gamco Investors INC. ET AL now owns 670,781 shares of the industrial products company's stock valued at $4,662,000 after buying an additional 18,305 shares during the last quarter. Renaissance Technologies LLC lifted its position in shares of LGL Group by 3.6% during the 1st quarter. Renaissance Technologies LLC now owns 166,594 shares of the industrial products company's stock worth $1,158,000 after buying an additional 5,773 shares in the last quarter. Finally, BlackRock Inc. bought a new position in shares of LGL Group during the 2nd quarter worth approximately $93,000. Institutional investors own 30.28% of the company's stock.

LGL Group Price Performance

Shares of NYSEAMERICAN:LGL opened at $7.60 on Friday. The firm has a fifty day moving average price of $7.02 and a two-hundred day moving average price of $7.07. The company has a market cap of $95.84 million, a price-to-earnings ratio of -190.00 and a beta of 0.32. LGL Group, Inc. has a one year low of $5.45 and a one year high of $7.81.

LGL Group (NYSEAMERICAN:LGL - Get Free Report) last posted its earnings results on Friday, August 14th. The industrial products company reported ($0.06) EPS for the quarter, missing the consensus estimate of $0.01 by ($0.07). The business had revenue of $0.75 million for the quarter, compared to analysts' expectations of $0.80 million. LGL Group had a negative return on equity of 0.51% and a negative net margin of 5.04%. Equities research analysts expect that LGL Group, Inc. will post -0.06 EPS for the current fiscal year.

Analysts Set New Price Targets

Separately, Zacks Research raised LGL Group to a "hold" rating in a report on Thursday, May 7th. One analyst has rated the stock with a Hold rating, Based on data from MarketBeat.com, the company currently has an average rating of "Hold".

LGL Group Profile

LGL Group Inc is a United States–based company specializing in the development and commercialization of digital pathology and molecular imaging systems for research and clinical laboratories. The company's core focus lies in enabling high-resolution visualization and quantitative analysis of tissue samples, helping scientists and pathologists accelerate biomarker discovery and diagnostic workflows. LGL Group's platform combines advanced optics, automated slide scanning and image analysis software to deliver end-to-end solutions tailored to oncology, immunology and neuroscience research.

The company's flagship offerings include whole-slide scanners capable of rapid, high-throughput scanning at resolutions suited for detailed morphometric and fluorescence studies.

Want to see what other hedge funds are holding LGL? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for LGL Group, Inc. (The) (NYSEAMERICAN:LGL - Free Report).

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest reporting and unbiased coverage. Please send any questions or comments about this story to contact@marketbeat.com.

Continue following MarketBeat

Add MarketBeat as your preferred source on Google to see our latest stories in your feed.

Add As Preferred Source